Tag:
Diversification
Latest Headlines
Latest Headlines
Samsung plans $260M foray into drug manufacturing
As drugmakers diversify into other businesses, another business is diversifying into drug-making. Samsung Electronics says it will sock $260 million into a joint venture with Quintiles, aiming to
Lilly CEO targets animal health, emerging markets
Big Pharma is preaching the gospel of diversification these days. Drugmakers are trying to offset future generic competition by broadening their reach, both product-wise and location-wise. But every
Pharma's road map for navigating industry change
We all know Big Pharma is going through an upheaval so far-reaching, it's like the prehistoric earthquakes and volcanic eruptions that made our mountains. To survive these changes , drugmakers are
Post-reform pharma should follow the money
What's pharma's best bet in the post-healthcare reform world? Avoiding the government. No, that's not like running from the police. It's more like luxury marketing: Targeting your business toward the
Is diversification really such a great idea?
Datamonitor has struck a blow against diversification in pharma. The market research firm points out that many Big Pharma firms are putting more and more eggs in other baskets besides prescription
Sanofi to buy vitamin maker for $543M
SPOTLIGHT: Sanofi to buy vitamin maker for $543MMIn another instance of Big Pharma diversification, Sanofi-Aventis inked a deal to buy Primary Health Care's vitamin-making unit for $543.4 million;
GSK's Witty opts out of generics market
When it comes to diversifying through generics, count GlaxoSmithKline out. CEO Andrew Witty says he has no interest in duking it out in that marketplace. Not only does generics success depends on low
Survey: Pharma tries "selling outcomes"
Where's the growth? According to a Financial Times survey, a quarter of pharma execs agree that diversifying away from medications and stepping up sales in emerging markets are the way to go.
